Got To Meet The Queen Cannabis 🌿 TRULIEVE CEO Kim Rivers Today. Thank You For Your Southern Hospitality And Charm 💚 It Was So Awesome To Finally Meet In Person 👸🏼 Made My Year!!! Let’s Go! #Onward $TRUL $TCNNF @Trulieve @rivers_kim
Glass House Brands (NYSE:GLAS) Under Investigation by Highful Law PLLC
Highful Law PLLC Investigates Glass House Brands Inc. for Potential Securities Claims After Auditor Resignation
$GLAS $MSOS
https://t.co/VpjimjXH5H
@KobeissiLetter They obviously have more information and visibility to possible (civil and or criminal) litigations. Not to mention all the Congressional oversight that's coming their way.
THE LABOR DEPARTMENT JUST DROPPED NEW WAGE DATA AND IT'S BRUTAL.
Corporate profits up 47% since 2020.
Worker wages up 12% in the same period.
Meanwhile groceries up 35%, rent up 40%, utilities up 28%.
Your paycheck grew 12%. Your bills grew 35%.
The math is simple: you're getting poorer every year even when you get a raise.
You can't budget your way out of this. The system is designed so your income can never catch up to your expenses.
That's not an accident. That's policy.
Companies raised prices after US tariffs. Now they’re getting millions in refunds and some are using the money to pay executives, while shoppers who paid more get nothing back, as Al Jazeera’s @emma_withrow reports.
🚨 UPDATE: Trulieve Cannabis @Trulieve@Trulieve_IR (NYSE: $TRLV) has been added to FTSE Russell’s preliminary additions list for the Russell 3000 as part of the December 2026 reconstitution.
This follows Rank Day on October 30. The preliminary list was published after the close today (November 13). Changes take effect after the close on December 11, with trading opening under the new membership on December 14.
**Why it matters:**
Index funds tracking the Russell 2000 and 3000 (including $IWM, with roughly $78B in assets) would become forced buyers. Prior estimates pointed to 10–15 million shares of demand—about 6–9% of Trulieve’s ~162 million share float—on top of ongoing buybacks. That is material relative to typical volume and should improve liquidity.
**Context:**
This is the next milestone after Trulieve’s historic June 10 NYSE listing (the first major U.S. plant-touching cannabis company) and its September additions to the S&P Total Market Index, S&P Completion Index, and related health-care sub-indices. Those followed its Delaware domestication and the federal rescheduling of state-licensed medical marijuana to Schedule III, which also enabled DEA registrations.
As the largest U.S. medical cannabis operator and roughly 37% of the MSOS ETF, Russell inclusion would expand the passive ownership base and serve as a template for other operators that clear similar eligibility screens.
Updates to the preliminary list are expected on November 20, 27, and December 4 before the reconstitution locks in.
🚨 Texas Lt. Governor Dan Patrick: “I’m not going to legalize marijuana and if people want to vote me out of office for that, so be it.”
He has now been voted out of office.
🗞️ Trulieve @Trulieve $TRLV Receives DEA Registrations for State-Licensed Medical Marijuana Operations
🔥-take: Trulieve just locked in federal legitimacy for its pure medical operations while most of the multi-state operator field are waiting on full rescheduling.
🗣️ Kim Rivers @rivers_kim@Trulieve CEO
"Today marks another historic milestone for patients, physicians, and Trulieve, made possible by the bold action taken by the Trump Administration on common sense cannabis reform. Federal reclassification of state licensed medical marijuana opens the door for clinical research while creating a level playing field for responsible operators like Trulieve. We appreciate the DEA's work to advance this historic change and its continued engagement with state-licensed medical cannabis operators as the new federal framework is implemented."
🤖 ANALYSIS
Trulieve’s announcement that it received DEA registrations for its state-licensed medical marijuana dispensaries is a concrete milestone, not just another press release. It forms part of the DEA’s initial wave of federal registrations issued under the Attorney General’s April order that moved qualifying state-licensed medical marijuana to Schedule III while keeping controls under the Controlled Substances Act. Trulieve applied promptly after that rescheduling and is among the operators now in the first batch covering hundreds of dispensaries across states including Florida, West Virginia, and others. CEO Kim Rivers framed it as another historic step enabled by the Trump administration’s approach, noting it opens doors for clinical research and a more level playing field for compliant operators.
For $TRLV specifically, the impact is immediate and structural. The company had already reorganized to ring-fence its medical-only operations (Florida, Georgia, Pennsylvania, West Virginia) from mixed medical/adult-use assets, enabling its NYSE listing earlier this year as the first U.S. plant-touching cannabis operator on a major exchange. Confirming the DEA registrations solidifies that structure: the listed entity’s consolidated operations are DEA-registered medical facilities operating under the new federal framework. This underpins the removal of the punitive Section 280E tax burden on those medical operations (ordinary business expenses can now be deducted), which management has indicated improves net income, cash flow, and the cost of capital. It also supports research pathways and reduces some of the legal overhang that has long deterred traditional institutional capital and banking. With a large Florida footprint, high margins relative to peers, and strong cash generation already reported, this reinforces Trulieve’s competitive moat in medical-only markets and its ability to reinvest or pursue selective expansion (Georgia pharmacies, Texas conditional licenses) with a cleaner federal posture. The stock’s positive reaction on the news aligns with that narrative of differentiation.
The picture is more nuanced for peers like $CURLF and $GTBIF. These larger multi-state operators have substantial mixed medical and adult-use footprints. Only the portions that qualify as pure state-licensed medical operations under the order can pursue (and potentially receive) the same DEA registration pathway and associated 280E relief. Adult-use activities remain outside this framework and continue under Schedule I constraints, including the full 280E tax hit, banking friction, and limited institutional access. Broader rescheduling for non-medical marijuana has faced procedural pauses and delays, so full-sector tax and capital-market normalization is not yet here. Operators that registered some medical assets (as Curaleaf has indicated in the past) gain partial benefits, but the scale of relief is smaller relative to their overall revenue base than it is for a medical-focused, already-restructured player like Trulieve. This creates a temporary bifurcation: pure or cleanly separated medical operators capture more near-term cash-flow and valuation upside, while mixed MSOs face pressure to restructure, prioritize medical segments, or simply wait. Industry-wide, the issuance of 900+ registrations is a positive legitimacy signal that could gradually improve sentiment and research activity, but it does not eliminate competitive intensity or the remaining federal limits on interstate commerce and recreational markets.
In short, this news is a clear win for Trulieve’s positioning, margins, and investor story. For the broader group including Curaleaf and Green Thumb, it is constructive but incomplete—highlighting both the progress on medical cannabis and the still-unfinished work on full federal reform. Execution on compliance, continued cash generation, and any further policy movement will determine how much of the potential translates into sustained stock performance.
🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS
https://t.co/MfIdzp15by
@Robert_Munnich Who cares what Justin Williams thinks, the Flames are having fun and winning. A little different story if you were down in the game and pulled that.
@AdamSchein You thought Jaylen was blameless on last week’s overtime gaffe and you were wrong. Just like tonight’s 4th down throw away…. No situational awareness in the slightest…